HighVista Strategies’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

HighVista Strategies’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13,932	Closed	-$105K	–	135
2021 Q3	$105K	Buy	+13,932	New	+$89.2K	0.07%	94
2021 Q1	–	Sell	-10,100	Closed	-$93K	–	148
2020 Q4	$93K	Sell	10,100 -3,900	-28%	-$33.9K	0.06%	93
2020 Q3	$97K	Buy	+14,000	New	+$84.9K	0.07%	80

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HighVista Strategies's SURF Position: Q4 2021 in Review

HighVista Strategies sold out of Surface Oncology, Inc. Common Stock (SURF) in Q4 2021, closing a stake of 13,932 shares — an estimated $105K sold.

HighVista Strategies first reported a position in SURF in Q3 2020 and held it in 3 quarters. The position peaked at $105K in Q3 2021. 106 funds tracked by Wall St. Rank hold SURF as of Q4 2021.

HighVista Strategies reported no remaining Surface Oncology, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
HighVista Strategies sold 13,932 Surface Oncology, Inc. Common Stock shares in Q4 2021, an estimated $105K.
HighVista Strategies first reported a position in Surface Oncology, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
HighVista Strategies's Surface Oncology, Inc. Common Stock position peaked at $105K in Q3 2021.
106 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q4 2021.

Based on HighVista Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.